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Abstract
We report tree-based association analysis as applied to the two Framingham cohorts and to the
first replication of the simulated data obtained from the Genetic Analysis Workshop 13. For this
analysis, familial association is ignored. The two endpoints examined are hypertension status at
initial visit and time-to-hypertension, using a censored data approach. Although linkage association
has previously been reported with hypertension, we found no association using the tree-based
methodology.
Background
The Framingham Heart Study is a rich data set filled with
information about hypertension status in a population-
based cohort observed over an extended period of time. As
shown by Levy et al. [1] and Hunt et al. [2], there is strong
indication that there is a genetic component to this dis-
ease, thus making the data ideal for exploring the strength
of tree-based models in detecting similar results. Tree-
structure models can be accurate classifiers (binary out-
come) and predictors (quantitative outcome), and often
yield better understanding to the underlying structure of
the data relationship [3]. The use of tree-structure models
is advantageous because no assumptions are necessary to
explore the data structure and to derive parsimonious
models. These models handle data of complex structure
and missing data at each node; interactions are part of the
tree building process. By using tree-structure methods, we
set out to identify homogeneous groups by partitioning
the genetic and environmental data using the recursive
partitioning algorithm. As shown in Zhang and Bonney
[4], classification trees can be used to correctly identify
disease alleles. The purpose of this paper is to determine
how well the recursive partitioning methodology detected
a genetic association using two different measures of
hypertension status: hypertension status at the initial visit
and a censored data approach, where time is measured on
the age scale.
Materials and Methods
Data
Our analysis focused on the two Framingham cohorts and
the first replicate of the simulated cohorts. Cohort 2 was
also used for validation of results obtained from the
Cohort 1 analyses. Answers were obtained for the simu-
lated data. In the Framingham study partial data were
available on 1213 of the original (largely unrelated)
Cohort 1 subjects and 1668 of the original (familial)
Cohort 2 subjects. However, in Cohort 1 only 32% of the
subjects had genetic marker data; in Cohort 2 the number
was much higher (78%) though there were still a large
number of uninformative subjects. Although the tree
models can handle missing data through the use of surro-
gate variables, we felt that the large number of observa-
tions with completely missing genetic data warranted
their deletion. In addition, the age ranges of the two
cohorts varied, hence we focused the analysis on the 390
Cohort 1 subjects and the 726 Cohort 2 subjects with
genetic marker information who were between 30 and 55
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years of age at the initial visit. Similar limiting of the sim-
ulated data resulted in 346 Cohort 1 subjects and 1060
Cohort 2 subjects. We defined two primary response vari-
ables based on the available phenotype data and models
were fit separately for each of the two cohorts. We first
looked at hypertension status at the baseline visit (22% of
Framingham Cohort 1, 20% of Framingham Cohort 2,
6% of Simulated Cohort 1, and 8% of Simulated Cohort
2). Three Framingham Cohort 2 subjects who were being
treated for hypertension at the baseline visit but were not
diagnosed with hypertension were removed from the
analysis. Our second end-point used a censored "time-to-
hypertension" approach, in which age was used as the
time scale. Subjects entered the risk set at their first visit
and exited the risk set when they were lost to follow up
(censored) or were diagnosed with hypertension. For
those subjects that did not already have hypertension at
their first visit, 52% of Framingham Cohort 1 and 29% of
the Framingham Cohort 2 went on to develop the disease
by age 55. The simulated cohorts each had estimates
around 30% at age 55. Subjects who started treatment for
hypertension before diagnosis of hypertension were cen-
sored at the time of treatment (this occurred in less that
2% of the subjects in each cohort). The 398 genetic mark-
ers were used as predictors along with the environmental
variables of age, sex, cigarettes per day, body mass index,
and alcohol consumption. The markers were expanded so
that every allele of every marker created a new allelic vari-
able. For instance, chromosome 1, marker 1, allele 1
(c1m1a1) could have the values 0, 1, or 2 depending on
how many copies of the mutation an individual carried.
This resulted in the creation of over 4400 predictors.
Statistical methods
Construction of trees using recursive partitioning necessi-
tates defining a splitting rule and pruning rule. Splitting
rules are used to examine all possible splits of the full
group of subjects (root node) and to identify the variable
at each level that produces the most homogenous chil-
dren. For classification endpoints like "hypertension at
visit one", impurity is used to determine the best split.
Impurity, or the diversity, of a node A can be written as
, where C is the number of end-point
classes (in our case 2), piA is the proportion of those in
node A that belong to class i, and f is some impurity func-
tion. If node A is pure then I(A) = 0. For the classification
end-point "hypertension at visit one" we used the impu-
rity function called the Gini index where f(p) = p(1 - p)
and we used the split which maximized the impurity
reduction  ∆I  =  p(AParent)I(AParent) - p(ALeft)I(ALeft) -
p(ARight)I(ARight). For the censored "time-to-hypertension"
end-point we used a splitting criterion which is equivalent
to a likelihood ratio test for two Poisson groups: DParent -
(DLeft  +  DRight). The deviance
, where ci is the observed event count for observation i, ti
is the scaled observation time, and
  
is the predicted rate of the node. The time variable is mod-
ified slightly using exponential scaling to get a straight line
curve for log(survival) under a parametric exponential
model [5]. This is equivalent to the local full likelihood
tree model by LeBlanc and Crowley [6].
For pruning we chose to use a fixed complexity parameter
of 5% and the 1-SE rule. The complexity parameter α is a
measure of improvement in the tree impurity. Heuris-
tically, the tree building process can be compared to for-
ward step-wise regression, where variables (splits) are
made until the F-test of the remaining variables fails to
achieve some level of α. An α level of 5% suggests that fur-
ther splits will add less than 5% to the overall fit of the
tree. The 1-SE rule uses cross-validation, which involves
randomly partitioning the original samples into 10 fitted
sub-samples and computing an average misclassification
rate for each sub-tree (corresponding to the different
splits). The sub-tree with the smallest average misclassifi-
cation rate is identified, as are all sub-trees that have an
average misclassification rate within one standard error of
this smallest rate (also obtained from the cross-valida-
tion). The simplest model is picked. Thus, we identified a
sub-tree that provides the least complexity and the least
misclassification of subjects. All recursive partitioning
models were fit using the SPLUS library rpart [5], a pack-
age that closely resembles the original CART package [3].
Results
Hypertension status at Visit 1
Analysis of the Framingham Cohort 1 data examining
"hypertension at visit one" as built to the complexity
parameter of 5% includes the environmental variables age
and body mass index (BMI), and 11 different markers:
c10m5a5, c12m17a7, c17m7a7, c19m8a1, c1m32a4,
c2m21a3, c2m21a6, c2m2a11, c5m20a1, c6m12a7 and
c6m13a7. No variables remain in the model after pruning
using the 1-SE rule. Results are similar when only marker
data is used or when only a subset of the marker data is
used (using alleles that appear > 1% or < 99% of the time
results in 30% fewer allele variables). Analysis of the
Framingham Cohort 2 data resulted in similar conclu-
sions, with no variables remaining after pruning with the
1-SE rule.
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Table 1 summarizes the results when the complexity
parameter is set to 5%. Although the classification error is
marginally improved with the splits (using no splits, the
misclassification is 22.1% and it is 17.4% with five termi-
nal-nodes when looking at a model with only marker
data), the mean cross-validation error is higher (in this
case 26.9%). The misclassification rate, when the model
from Cohort 1 is applied to Cohort 2, also worsened
(20.2% to 22.7% in the marker only case). Results were
similar for the simulated data (see Table 2), including the
analysis that only included markers that were close to the
underlying genes that were used in the creation of the sim-
ulated data. Careful inspection of the individual splits
illustrates further the instability of these models. In most
cases the improvement gained by using a given allele var-
iable is only marginally better than the improvement
gained by a totally different allele (often from a different
marker or chromosome). Sometimes the "improvement"
only differed in the 5th decimal point.
Time-to-hypertension
As is illustrated in Figure 1, the probability of developing
hypertension clearly increases as age increases. Thus, an
end-point accounting for this change over age should
result in a better endpoint. However, none of the "time-
to-hypertension" Framingham models improved the
node purity by at least 5%. Examination of the cross-vali-
dation errors when the trees were grown to their maxi-
mum size (complexity parameter set to zero) indicated
that no splits were necessary. Results were similar for the
simulated data.
Discussion
Although the recursive partitioning approach should be
ideal for detecting sub-populations of individuals that
have hypertension, we were unable to detect any associa-
tion between the hypertension status and the 398 genetic
markers. Similarly, because hypertension is highly age-
related the end-point using a censored "time-to-hyperten-
sion" approach, where age was used as the time scale,
should have been useful for separating out subjects who
perhaps had earlier onset of the disease. Neither method-
ology found any consistent positive results. A large pro-
portion of the subjects did not have genetic marker data
and were thus deleted (68% of the Framingham Cohort 1
subjects and 22% of the Cohort 2 subjects) whereas in a
familial analysis some of the markers could have been
estimated from family members. In the Framingham
Cohort 1, those without marker data were on average
older, heavier, smoked more, drank more and had, at
baseline, more hypertension (41.5% vs. 22.1%). The
same patterns were also seen in Cohort 2, though the dif-
ferences were not as great. Because the missing patterns
are significantly related to hypertension status, this prob-
Table 1: Misclassification rates of the Framingham Cohort 1 models predicting hypertension at visit 1.
ModelA Number of End-nodes Cohort 1 Observed 
Error
Cohort 1 Cross-
validation
Cohort 1 Model 
Applied to Cohort 2
1) No Splits 1 22.1% 22.1% 20.2%
2) All M & E 3 18.5% 23.1% 21.6%
3) All M 5 17.4% 26.9% 22.7%
4) All E, subset of M 3 18.5% 23.1% 21.6%
A1) no splits; 2) all allelic markers and environmental factors; 3) all allelic markers; and 4) all environmental factors but only those allelic markers 
that occur at least 1% of the time or less than 99% of the time. All models shown have a complexity parameter of 5%.
Table 2: Misclassification rates of the simulated (Replication 1) Cohort 1 models predicting hypertension at visit 1.
ModelA Number of End-nodes Cohort 1 Observed 
Error
Cohort 1 Cross-
validation
Cohort 1 Model applied 
to Cohort 2
1) No Splits 1 6.4% 6.4% 7.9%
2) All M & E 3 5.5% 6.6% 10.1%
3) All M 3 5.5% 6.6% 10.1%
4) All E, subset of M 3 5.5% 6.6% 10.1%
5) All E, handpicked M 1 6.4% 6.4% 7.9%
A1) no splits; 2) all allelic markers and environmental factors; 3) all allelic markers; 4) all environmental factors but only those allelic markers that 
occur at least 1% of the time or less than 99% of the time; and 5) all environmental factors but only those allelic markers that occur near the region 
of the underlying disease genes. All models shown have a complexity parameter of 5%.BMC Genetics 2003, 4 http://www.biomedcentral.com/1471-2156/4/s1/S63
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ably introduced bias into the study, perhaps making
meaningful associations more difficult to find. Another
problem could be that hypertension is too common a
condition for study using this methodology (the cumula-
tive incidence at age 80 is over 80% (Figure 1). The cen-
soring of data when hypertension treatment preceded
diagnosis occurred in less than 10% of the cases, but
might have marginally influenced the results. However, it
is unclear how those subjects should be coded since time
to diagnosis would surely be influenced by treatment.
Finally, perhaps sample size was an issue, especially in
Cohort 1, in which 390 subjects were used for the case/
control status and 304 subjects were used for the "time-to-
hypertension" endpoint.
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Time to hypertension in the Framingham cohorts Figure 1
Time to hypertension in the Framingham cohorts Survival curves for Cohorts 1 and 2 of the Framingham study, using a 
censored "time-to-hypertension" approach, where age is used as the time scale (p = 0.001).